Glaucoma

Mitch Ibach, OD, FAAO and Michael Greenwood, MD review their SECO 2022 presentation on comanaging glaucoma

Lee Peplinski, OD, FAAO, emphasizes the importance of interventional care in patients with glaucoma.

Other factors, besides IOP, can contribute to glaucomatous optic nerve damage

See our latest poll results

New platform has potential to overcome challenges of legacy technology

Sustained-release injectables may be key to addressing the greatest obstacles in glaucoma.

Oluwatosin Smith, MD, reviews different applications of minimally invasive glaucoma surgeries (MIGS) to find the best option, with the best outcome, for every patient.

Risk factors take priority

The future is sustained-release injectables

Andrew G. Iwach, MD, shares a few key highlights from his presentation regarding trend challenges of glaucoma.

Oluwatosin U. Smith, MD, speaks shares the highlights of her presentation exploring remote monitoring of glaucoma and the future of virtual care on the whole.

Industry keenly focused on innovations

Ranya Habash, MD, shares a sneek peek of her New Horizions keynote speech on "The future of eye care: science fiction to science fact," during the 2022 Glaucoma 360 meeting.

Revolutionized treatment offers favorable safety profile, quick postop recovery

The removal of preservatives may be beneficial for the ocular health of glaucoma patients

Weigh in on our poll!

Advancements in medications and lasers bring better adherence and outcomes.

Reducing the burden of drops can improve patients’ QOL and prevent progression of glaucoma.

Emotional health can potentially affect patient care, study results show

Practitioners spend more time diagnosing glaucoma or diabetic retinopathy than AMD

Cases illustrate how acute and chronic angle-closure glaucoma are treated

Tackle one of the biggest challenges in managing patients with glaucoma